EGFR

:   epidermal growth factor receptor

Gab1

:   Grb2‐associated bind protein 1

Grb2

:   growth factor receptor‐bound protein 2

HGF/SF

:   hepatocyte growth factor/scatter factor

imFCS

:   imaging fluorescence correlation spectroscopy

InlB

:   internalin B

MCD

:   methyl‐β‐cyclodextrin

MSD

:   mean square displacement

NA

:   numerical aperture

PLL‐PEG

:   poly‐L‐lysine‐grafted polyethylene glycol

ROI

:   region of interest

RTK

:   receptor tyrosine kinases

TIRF

:   total internal reflection fluorescence

TrkA

:   neurotrophin receptor tropomyosin‐related kinase A

uPAINT

:   universal point accumulation for imaging in nanoscale topography

Receptor tyrosine kinases (RTKs) are transmembrane receptors which are bound and activated by a variety of ligands, including growth factors, differentiation factors, and hormones [1](#feb412285-bib-0001){ref-type="ref"}. RTKs represent the primal elements of several cellular signaling cascades and exhibit distinct regulative effects on cellular proliferation, differentiation, metabolism, motility, and cell‐to‐cell signaling. As receptor dynamics and interactions are involved in a series of cellular processes, research on this topic is particularly worthwhile. Mutations in RTK‐encoding gene sequences may result in altered functions or structures, while alterations in regulatory domains cause receptor overexpression, all of which are thought to trigger or promote various diseases such as different types of cancer, inflammation, and diabetes. This renders RTKs important targets for many pharmaceutical therapies [1](#feb412285-bib-0001){ref-type="ref"}, [2](#feb412285-bib-0002){ref-type="ref"}.

MET belongs to the RTK family and is found in various eukaryotic cells including those of humans. Upon activation by its native ligand, hepatocyte growth factor/scatter factor (HGF/SF), the MET receptor triggers intracellular signaling cascades which result in various cellular responses such as cell motility and growth [3](#feb412285-bib-0003){ref-type="ref"}. MET signaling is attenuated by receptor internalization and degradation [4](#feb412285-bib-0004){ref-type="ref"}, [5](#feb412285-bib-0005){ref-type="ref"}.

MET is also targeted by *Listeria monocytogenes*. This pathogenic bacterium can mediate a bacterial infection of the central nervous system through its surface proteins internalin (InlA) and internalin B (InlB) [6](#feb412285-bib-0006){ref-type="ref"}. InlB activates MET and initiates signaling pathways and endocytosis analog to HGF/SF [6](#feb412285-bib-0006){ref-type="ref"}, [7](#feb412285-bib-0007){ref-type="ref"}. Internalization of active InlB/MET complexes is mediated by clathrin‐coated pits [8](#feb412285-bib-0008){ref-type="ref"}, while lipid domains in the cell membrane are crucial for uptake of *L. monocytogenes* into host cells [9](#feb412285-bib-0009){ref-type="ref"}. It was shown that a fragment of InlB comprising amino acids 36--321, InlB~321~, is sufficient to bind and activate MET [10](#feb412285-bib-0010){ref-type="ref"}. Previous single‐molecule studies used InlB~321~ binding to investigate the oligomeric state of MET. It was found that the resting MET receptor is present as monomer and dimer and that binding of InlB~321~ increases the fraction of dimers [11](#feb412285-bib-0011){ref-type="ref"}.

Functional properties of proteins in the plasma membrane are regulated by its lipid and protein composition and by interactions between biomolecules within the membrane as well as with intracellular proteins [12](#feb412285-bib-0012){ref-type="ref"}. A variety of drugs are available which influence specific components of this complex network [13](#feb412285-bib-0013){ref-type="ref"} and aid in identifying those interactions that are relevant for a particular membrane protein. In terms of lipids, cholesterol is an important component of the membrane affecting its structure, fluidity, and functionality as well as several processes occurring at the membrane [14](#feb412285-bib-0014){ref-type="ref"}. Methyl‐β‐cyclodextrin (MCD) encapsulates cholesterol and swiftly depletes it from cell membranes [15](#feb412285-bib-0015){ref-type="ref"}. Additionally, it mainly inhibits clathrin‐mediated endocytosis by preventing the invagination and pinching‐off of clathrin‐coated pits, resulting in numerous flat, clathrin‐coated pits on the cell surface. It also affects caveolae‐dependent endocytosis pathways [16](#feb412285-bib-0016){ref-type="ref"}, [17](#feb412285-bib-0017){ref-type="ref"}. Nystatin is able to chelate and deplete cholesterol. It inhibits caveolae‐dependent endocytosis by flattening caveolae at the cell surface [18](#feb412285-bib-0018){ref-type="ref"}.

The plasma membrane is further organized by cytoskeletal proteins. Actin filaments are crucial components of the cytoskeleton, organize the cytoplasm, and determine cell shape. The dynamic polymerization of actin and subsequent reshaping of the cell membrane orchestrate cell migration and endocytosis [19](#feb412285-bib-0019){ref-type="ref"}. Actin partitions the membrane into domains and provides anchoring sites for membrane proteins [20](#feb412285-bib-0020){ref-type="ref"}. Cytochalasin D is able to bind actin, preventing association of further actin monomers, rupturing already existing actin polymers, and disrupting the supramolecular organization of the actin cytoskeleton [21](#feb412285-bib-0021){ref-type="ref"}. Latrunculin A binds to actin monomers, inhibiting further actin polymerization and depolymerizing actin filaments [22](#feb412285-bib-0022){ref-type="ref"}. Microtubules are another component of the cytoskeleton. They are responsible for cell shape and play a role in cellular transport [23](#feb412285-bib-0023){ref-type="ref"}. Colchicine binds to tubulin, preventing assembly into microtubules. Depolymerization of microtubules accelerates with increasing colchicine concentration as lateral contacts between tubulin molecules attenuate [24](#feb412285-bib-0024){ref-type="ref"}.

Manipulating cells with cytotoxins allows the identification of molecular interactions and mechanisms. Sensitive microscopy and spectroscopy methods, such as single‐molecule tracking or fluorescence correlation spectroscopy, read out diffusion dynamics of membrane receptors in live cells and report on diffusion types and diffusion coefficients. These observables are sensitive to subtle alterations of protein dynamics within the membrane and, if investigated under different cellular conditions, allow the deduction of mechanistic aspects of receptor activation and internalization.

In this study, we investigated the diffusion of resting and InlB‐bound MET within the plasma membrane of living cells using single‐particle tracking following the uPAINT protocol [25](#feb412285-bib-0025){ref-type="ref"} and imaging fluorescence correlation spectroscopy (imFCS) [26](#feb412285-bib-0026){ref-type="ref"}, [27](#feb412285-bib-0027){ref-type="ref"}. Both methods apply TIRF illumination, which allows selective excitation of labeled ligands bound to receptors at the basal cell membrane under exclusion of background fluorescence from regions deeper in the cell. We investigated how MET diffusion is influenced if cells are treated with cytotoxins that deplete cholesterol or affect actin polymerization. We determined diffusion coefficients and identified populations of diffusion types of single MET receptors by analyzing trajectories using fluorophore‐labeled ligands. We found that InlB‐bound MET exhibits lower average diffusion coefficients than resting MET. We show that the perturbation of actin polymerization resulted in increased diffusion coefficients for InlB‐bound MET, whereas resting MET was not affected. Treatment with MCD, which inhibits clathrin‐mediated endocytosis but may also affect caveolae‐dependent internalization, resulted in distinctly decreased diffusion coefficients for InlB‐bound MET and slightly lower diffusion coefficients for resting MET; treatment with nystatin, which inhibits caveolae‐dependent endocytosis, had a small effect on the diffusion of resting MET, but not on diffusion of the InlB/MET complex.

Materials and methods {#feb412285-sec-0002}
=====================

Coverslip passivation and functionalization {#feb412285-sec-0003}
-------------------------------------------

25‐mm borosilicate glass coverslips (VWR International, Radnor, PA, USA) were passivated with poly‐L‐lysine‐grafted polyethylene glycol (PLL‐PEG) to minimize unspecific interactions with the glass surface and partly functionalized for cell adhesion with a peptide (CG**RGD**S) containing the motif arginyl‐glycyl‐aspartic acid (RGD) [28](#feb412285-bib-0028){ref-type="ref"}. PLL‐PEG‐RGD was a kind gift of Jacob Piehler (Osnabrück University). Coverslips were sonicated (Sonorex SUPER RK 102H, Bandelin, Berlin, Germany) in isopropyl alcohol (Sigma‐Aldrich, St. Louis, MO, USA) for 20 min at 23 °C, rinsed with bidistilled water (Arium Pro Ultrapure Water Systems, Sartorius, Goettingen, Germany), dried with nitrogen, and plasma cleaned for 10 min at 80% power and 0.2--0.3 mbar (Zepto B; Diener Electronic GmbH, Ebhausen, Germany). Ten microlitre of 0.8 mg·mL^−1^ PLL‐PEG‐RGD solution in 1 × phosphate‐buffered saline (PBS) pH 7.4 (prepared from 10 × concentrate, catalog\# D1408; Sigma‐Aldrich) was incubated between two coverslips for approximately 90 min at 23 °C. Coverslips were separated by rinsing with bidistilled water, dried with nitrogen, and stored at −20 °C until further use in six‐well plates (Greiner Bio‐One International GmbH, Frickenhausen, Germany) covered with argon.

Cell culture {#feb412285-sec-0004}
------------

All experiments were performed in HeLa cells (Institut für angewandte Zellkultur, Munich, Germany). Cells were cultivated in growth medium (GM) consisting of high glucose Dulbecco\'s modified Eagle medium (DMEM) (Gibco, Life Technologies, Waltham, MA, USA) with 1% GlutaMAX (Gibco, Life Technologies) and 10% fetal bovine serum (Gibco, Life Technologies) in cell culture flasks (250 mL, 75 cm^2^; Greiner Bio‐One, Kremsmuenster, Austria) at 37 °C and 5% CO~2~ in an automatic CO~2~ incubator (Model C 150; Binder GmbH, Tuttlingen, Germany) for three to four days. When a cell passage needed to be split, GM was removed from the flask. After cells were rinsed with Dulbecco\'s PBS (Gibco, Life Technologies), 2 mL trypsin solution (0.05% trypsin, 0.02% EDTA; Invitrogen, Waltham, MA, USA) was added and incubated for 3 min at 37 °C to detach cells. Cells were suspended in 10 mL GM and centrifuged at 300 ***g*** for 3 min (Multifuge X1R; Thermo Scientific, Waltham, MA, USA). Cells were resuspended in GM, and a fraction was filled into a new cell culture flask with 15 mL fresh GM.

For experiments, HeLa cells were seeded onto PLL‐PEG‐RGD‐coated coverslips in six‐well plates. Each well was filled with 2 mL GM containing 5 × 10^4^ cells. Subsequently, the well plate was incubated at 37 °C and 5% CO~2~ for 3 days. Prior to measurements, coverslips were transferred to custom‐made coverslip holders. According to the intended measurements, either solution of cytotoxins in GM or pure GM was added to the cells in the coverslip holder.

uPAINT {#feb412285-sec-0005}
------

### Sample preparation: fluorescent labeling of ligands {#feb412285-sec-0006}

InlB~321~ was expressed with a lysine mutated into a cysteine (K280C) and a native cysteine mutated into an alanine (C242A) in order to create a single site for maleimide coupling and at the same time prevent the formation of intramolecular disulfide bonds. These mutations do not impair MET binding [10](#feb412285-bib-0010){ref-type="ref"}, [29](#feb412285-bib-0029){ref-type="ref"}. The thiol group of the mutated cysteine was coupled to ATTO 647N maleimide (ATTO‐TEC, Siegen, Germany), and labeled InlB~321~ was purified according to Dietz *et al*. [11](#feb412285-bib-0011){ref-type="ref"}.

The antibody fragment 3H3‐Fab (produced from a high‐affinity, monoclonal antibody against the MET ectodomain) is able to bind but not activate MET. Fab was labeled by coupling ATTO 647N‐*N*‐hydroxysuccinimide ester (ATTO‐TEC) with lysines of the antibody fragment. 2.45 nmol of Fab and 9.8 nmol of ATTO 647N‐NHS ester (4 × dye excess) were dissolved in 100 μL of PBS with 20 m[m]{.smallcaps} NaHCO~3~ (pH 8) (Sigma‐Aldrich). The mixture was slightly shaken under exclusion of light for 2 h at 23 °C. Labeled Fab fragment was separated from unbound dye molecules by chromatography with a NAP‐5 column (GE Healthcare, Dornstadt, Germany), equilibrated with 10 mL PBS, and eluted with PBS. The concentration of the labeled ligand and the degree of labeling (DOL) were determined by absorption spectroscopy (Nanophotometer; Implen GmbH, Munich, Germany). A yield of 26% and a DOL of 164% were obtained. Both ligands were stored at −20 °C in protein LoBind tubes (Eppendorf GmbH, Hamburg, Germany).

### Sample preparation: staining for uPAINT {#feb412285-sec-0007}

uPAINT measurements were taken at 23 °C and at 32 °C. Approaches for the respective conditions differ slightly. For measurements at 23 °C, 600 μL of GM was pipetted onto the cells in the coverslip holders, and left to gradually cool to 23 °C for 15 min. Then, the coverslip was rinsed once with 600 μL of serum‐free imaging medium (IM) containing high glucose DMEM with 1% GlutaMAX and 50 mM HEPES buffer (pH 7.2--7.5; Gibco, Life Technologies). Fresh solutions of both labeled ligands, InlB~321~ and Fab, were prepared with concentrations of 50 n[m]{.smallcaps} in IM. Three microlitre of the respective solution and 597 μL of IM were mixed on the coverslip resulting in a final ligand concentration of 0.25 n[m]{.smallcaps}.

For measurements at 32 °C, the glass coverslip positioned in the coverslip holder was rinsed once with warm IM. 599 μL of IM was added and the coverslip was positioned onto the objective of the microscope, which was heated to 37 °C and allowed to acclimate for 10 min. The temperature in the sample itself was 32 °C. 1.2 μL of the respective fresh 50 n[m]{.smallcaps} ligand solution in IM was added to the solution in the coverslip holder (final concentration of ligand 0.1 n[m]{.smallcaps}) without removing the sample from the objective. For both temperature settings, a measurement was started approximately three minutes after the addition of a fluorescently labeled ligand so that the ratio of bound to unbound receptors was already balanced.

### Sample preparation: exposure to cytotoxins {#feb412285-sec-0008}

All cytotoxins were ordered from Sigma‐Aldrich. Stock solutions of nystatin, cytochalasin D, latrunculin A, and colchicine were prepared in dimethyl sulfoxide, while MCD was dissolved in bidistilled water. All solutions were stored at −20 °C.

Cells exposed to 600 μL of MCD (10 m[m]{.smallcaps}), nystatin (50 μ[m]{.smallcaps}), cytochalasin D (1 μ[m]{.smallcaps}), or colchicine (10 μ[m]{.smallcaps}) in GM were incubated for 15 min at 37 °C, while cells exposed to latrunculin A (1 μ[m]{.smallcaps}) were incubated for 10 min. Following incubation, coverslips were rinsed with 600 μL of GM. Ligand addition corresponded with the protocol described in the previous section. uPAINT measurements of cells exposed to cytotoxins were performed at 23 °C for each ligand.

### Setup and data acquisition {#feb412285-sec-0009}

Data were collected with a N‐STORM microscope (Nikon, Duesseldorf, Germany) with a 647‐nm laser for ATTO 647N excitation, applying total internal reflection fluorescence (TIRF) illumination. Measurements were started and controlled by the application of two software tools: Micro‐Manager [30](#feb412285-bib-0030){ref-type="ref"} and NIS Elements (Nikon). The objective (100 × Apo TIRF oil) had a 100 × magnification and a numerical aperture (NA) of 1.49 and could be adjusted to temperatures of 23 and 37 °C as well as to the thickness of the coverslips (0.17 mm). The frame transfer of the camera (DU‐897U‐CS0‐BV; Andor Technology, Belfast, UK) was used. A laser intensity of 0.1 kW·cm^−2^ and an EM gain of 200 were employed. The image size was limited to 256 × 256 pixels with a pixel size of 0.158 μm. Films were recorded with 1000 frames and an exposure and frame time of 20 ms. The laser was switched on only during measurements to minimize phototoxicity. On each coverslip, measurements were taken on 20 living cells, never exceeding an overall time period of 30 min per sample. Ten films of background were recorded on positions devoid of cells.

### Image analysis {#feb412285-sec-0010}

Films were analyzed using PALM‐Tracer (Bordeaux Imaging Center), which is a plugin for MetaMorph (Molecular Devices, Sunnyvale, CA, USA). The following settings were chosen: mean square displacement (MSD) fitting length was four points, and the maximum distance between two consecutive localizations was set at five5 pixels (790 nm); that is, points further apart were not connected to a trajectory. Only trajectories with a minimum length of 20 frames were accepted. The threshold was set according to the value with the lowest background signal within the last frame. Regions of interest (ROI) were set by manually outlining the shape of cells in the transmitted light images and subsequently transferring these outlines to the respective films. Background films were analyzed without the application of a ROI. The software finds localization points, fits them with a centroid function, and connects them according to the set criteria. Analysis yielded x‐y‐coordinates of each localization, MSD values, and diffusion coefficients for individual trajectories obtained by fitting the first four points of the MSD plots with Eqn [(1)](#feb412285-disp-0001){ref-type="disp-formula"}.$$\text{MSD}(\Delta t) = 4D\Delta t.$$

### Data analysis: generation of logarithmic diffusion coefficient histograms {#feb412285-sec-0011}

Sixty cells from at least two different days were selected for each treatment group. Diffusion coefficients for each trajectory of these cells were imported into Origin (OriginPro 2016G; OriginLab Corporation, Northampton, MA, USA) as well as the diffusion coefficients determined in background measurements. Data were log‐transformed and binned in the range between −5.3 and 1.0 with a bin size of 0.1 for each measurement. All frequency counts were normalized to 1 μm^2^. Frequency counts for the background measurements of one coverslip were averaged and subtracted from the respective frequency counts of each cell on the same coverslip. Frequency counts of background‐corrected cells were averaged over all selected 60 cells and normalized. Logarithmic diffusion coefficient values were re‐transformed. Frequency counts were plotted logarithmically against diffusion coefficients.

### Data analysis: dynamic localization precision {#feb412285-sec-0012}

The localization precision of dynamic particles in the recorded films was determined according to the method described by Michalet [31](#feb412285-bib-0031){ref-type="ref"}. The y‐intercept of the MSD plot MSD (0), the diffusion coefficient *D*, and the frame time 0.02 s influence the dynamic localization precision σ~dyn~ (Eqn [(2)](#feb412285-disp-0002){ref-type="disp-formula"}).$$\sigma_{dyn} = \sqrt{\frac{\text{MSD}{(0)} + \frac{4}{3}D \cdot 0.02s}{4}}.$$

Nine cells from three different days were selected for either InlB~321~ or Fab. Diffusion coefficients and MSD (0) values were averaged per cell. σ~dyn~ was calculated for all nine cells. The third quartile of these nine values was adopted as dynamic localization precision which amounted to 45.5E‐3 μm for InlB~321~ ATTO 647N in IM. The same value was applied to trajectories of Fab‐ATTO 647N in order to guarantee comparability of diffusion types for all samples.

### Data analysis: assignment of diffusion types {#feb412285-sec-0013}

Diffusion coefficients were assigned to three types of diffusion: immobile, confined, and free. The dynamic localization precision and the method described by Rossier *et al*. were used for the assignment [32](#feb412285-bib-0032){ref-type="ref"}. Particles were defined as immobile if their diffusion coefficient was lower than the lowest determinable value *D* ~min~ on the basis of the dynamic localization precision. *D* ~min~ was determined by rearranging Eqn [(1)](#feb412285-disp-0001){ref-type="disp-formula"} to calculate *D*. MSD(Δ*t*) was substituted with $\sigma_{dyn}^{2}$ , and (Δ*t*) corresponds to the time period of the first four MSD points 4·0.02 s as only these were fitted to determine the diffusion coefficient (Eqn [(3)](#feb412285-disp-0003){ref-type="disp-formula"}).$$D_{\min} = \frac{\sigma_{dyn}^{2}}{4 \cdot 4 \cdot 0.02\, s}.$$

According to this equation, the *D* ~min~ value for InlB~321~‐ATTO 647N in IM amounted to 6.5E‐3 μm^2^·s^−1^; that is, all particles with a diffusion coefficient smaller than this value were assigned as immobile. This value was applied for all treatment groups to ensure a comparable classification of diffusion. Further differentiation between confined and free diffusion was performed according to Rossier *et al*. [32](#feb412285-bib-0032){ref-type="ref"}.

### Data analysis: cumulative analysis of diffusion coefficients {#feb412285-sec-0014}

A second method to deduce diffusion types is a cumulative analysis according to the equations proposed by Gebhardt *et al*. [33](#feb412285-bib-0033){ref-type="ref"}. Cumulative frequencies were calculated for the logarithmic diffusion coefficients in an interval between −5.3 and 1.4 for each cell. These frequencies were averaged over 60 cells per treatment group and normalized. The logarithmic values were re‐transformed, and the cumulative frequencies were plotted against diffusion coefficient values on a logarithmic scale. These plots were fitted with an equation for one population (Eqn [(4)](#feb412285-disp-0004){ref-type="disp-formula"}) and for two populations (Eqn [(5)](#feb412285-disp-0005){ref-type="disp-formula"}).$$F{(D)} = A_{1}\left( {1 - \text{exp}\left( {- \frac{D}{D_{1}}} \right)} \right),$$ $$\begin{array}{cl}
{F(D) = \;} & {A_{1}\left( {1 - \text{exp}\left( {- \frac{D}{D_{1}}} \right)} \right)} \\
 & {+ {(1 - A_{1})}\left( {1 - \text{exp}\left( {- \frac{D}{D_{2}}} \right)} \right).} \\
\end{array}$$

*A* ~1~ represents the amplitude of the cumulative fit. In the case of two populations, it equals the fraction of molecules belonging to population 1, while (1 − *A* ~1~) represents the fraction of particles belonging to population 2. Residual curves were calculated and plotted to give an impression of the quality of the fits.

imFCS {#feb412285-sec-0015}
-----

### Sample preparation {#feb412285-sec-0016}

Staining for imFCS experiments was conducted in an analog fashion to uPAINT experiments. However, higher final ligand concentrations of 50 n[m]{.smallcaps} in IM needed to be applied to obtain sufficient signal to calculate autocorrelation curves. Samples were not exposed to any drugs.

### Setup and data acquisition {#feb412285-sec-0017}

The experimental setup for imaging FCS measurements used a 640‐nm diode laser (100 mW, Obis; Coherent, Santa Clara, CA, USA) as an excitation source passing through a telescope consisting of two achromatic lenses (Thorlabs, Munich, Germany) with *f* = −40 mm and 750 mm. A third achromatic lens (*f* = 400 mm; Thorlabs) directed the excitation light to the TIRF mirror and had its focus on the back focal plane of the objective. The position of the TIRF mirror was changed to switch between wide‐field and TIR illumination. The light entered an Eclipse Ti microscope (Nikon), was reflected by a dichroic mirror (zt532/640rpc; AHF, Tuebingen, Germany), and was directed onto the sample by an oil immersion TIRF objective (100 ×, NA 1.45; Nikon). Emission light was collected by the same objective, passed the dichroic mirror, and was detected by a scientific complementary metal oxide semiconductor (sCMOS) camera (Zyla 4.2; Andor Technology, South Windsor, CT, USA). The open‐source software Micro‐Manager was used for data collection. For data acquisition, the following settings were applied: 0.03 kW·cm^−2^ laser intensity (640 nm), a bit depth of 16 bit, fastest readout, exposure time 1 ms, frame time 1 ms, 4 × 4 binning, and 50 000 frames per film. Each film contained a 40 × 20 pixel ROI. On each coverslip, measurements were taken on up to 13 living cells, never exceeding an overall time period of 30 min per sample.

### Image analysis {#feb412285-sec-0018}

Analysis of imFCS films was performed with Imaging_FCS 1.47 [34](#feb412285-bib-0034){ref-type="ref"}, which is a plugin for ImageJ (NIH, Bethesda, MD, USA) [35](#feb412285-bib-0035){ref-type="ref"}. The following correlation settings were chosen: emission wavelength 669 nm for ATTO 647N, NA of 1.45, correlator scheme *P* = 16 and *Q* = 8, lateral PSF = 0.90, binning = 1, magnification 25 for 4 × 4 binning, and linear segment bleach correction with step width 5000. PSF calibration was performed according to Bag *et al*. [36](#feb412285-bib-0036){ref-type="ref"}. Diffusion coefficients were directly obtained for each pixel by fitting the correlation curves according to the literature [34](#feb412285-bib-0034){ref-type="ref"}.

### Generation of logarithmic diffusion coefficient histograms {#feb412285-sec-0019}

Sixty cells from three different days were selected for each ligand. Diffusion coefficients were imported into Origin. Data were log‐transformed and binned in the interval between −5.3 and 1.0 with a bin size of 0.1 for each cell. Frequency counts were averaged over all selected 60 cells and normalized. Logarithmic diffusion coefficients were re‐transformed. Frequency counts were plotted logarithmically against diffusion coefficients.

Statistics {#feb412285-sec-0020}
----------

If not stated otherwise, mean values are listed with respective standard errors of the mean (SEM, Δ). Average values and SEMs were determined for each cell. Overall means were calculated by averaging the mean values of 60 cells (Eqn [(6)](#feb412285-disp-0006){ref-type="disp-formula"}). The overall SEMs were determined according to Gaussian error propagation by averaging the SEMs of all 60 cells (Eqn [(7)](#feb412285-disp-0007){ref-type="disp-formula"}).$$D_{mean} = \frac{1}{60}\sum\limits_{i = 1}^{60}D_{i}.$$ $$\Delta D_{mean} = \frac{1}{60}\sum\limits_{i = 1}^{60}\frac{\delta D_{mean}}{\delta D_{i}} \cdot \Delta D_{i} = \frac{1}{60}\sum\limits_{i = 1}^{60}\Delta D_{i}.$$

*t*‐Tests were used to validate the comparison of mean values. Paired *t*‐tests (α = 0.05) were applied to compare means obtained by observations of the same cells, for example, free and confined diffusion coefficients of one treatment group. Two‐sample *t*‐tests (α = 0.05) were used to validate statements considering means of two different treatment groups, for example, the difference in diffusion coefficients of untreated cells compared to the diffusion coefficients of cells treated with a cytotoxin. Levels of significance were classified as follows: *P* \> 0.05 no significant difference between means (n.s.), *P* \< 0.05 significant difference (\*), *P* \< 0.01 very significant difference (\*\*),*P* \< 0.001 highly significant difference (\*\*\*). Datasets of all treatment groups were tested for normality by applying the Kolmogorov--Smirnov test (α = 0.1). All tests were performed in Origin.

Confocal laser scanning microscopy of cytotoxin‐treated cells {#feb412285-sec-0021}
-------------------------------------------------------------

### Sample preparation {#feb412285-sec-0022}

Exposure to cytotoxins was performed on living cells analog to the uPAINT experiments. Subsequently, cells were incubated in fresh GM at 23 °C for 15 min. These time intervals correspond to the periods of incubation before a uPAINT measurement. Control samples were prepared which were not exposed to any cytotoxin prior to staining and fixation.

### Actin staining {#feb412285-sec-0023}

After the removal of GM, cells were fixed by adding 600 μL of 4% (v/v) formaldehyde (Sigma‐Aldrich) in PBS and incubating for 10 min. Cells were rinsed three times with 600 μL of PBS and permeabilized with 600 μL of 0.1% (v/v) Triton X‐100 (TX) (Sigma‐Aldrich) in PBS for 10 min. Actin was stained with 600 μL of 13.2 n[m]{.smallcaps} phalloidin‐Alexa Fluor 647 (New England Biolabs, Hitchin, UK) in PBS for 10 min. Stained cells were rinsed with 600 μL of PBS. If not imaged immediately, coverslips were stored in PBS containing 0.05% (w/v) NaN~3~ (Roth, Karlsruhe, Germany) at 4 °C.

### Microtubules staining {#feb412285-sec-0024}

Cells were incubated in 600 μL of microtubule‐stabilizing buffer containing 80 m[m]{.smallcaps} PIPES (Sigma‐Aldrich), 1 m[m]{.smallcaps} MgCl~2~ (Sigma‐Aldrich), 5 m[m]{.smallcaps} EGTA (Sigma‐Aldrich), and 0.5% (v/v) TX. After 30 s, 0.5% (w/v) glutaraldehyde (Sigma‐Aldrich) was added and incubated for 10 min. The latter was quenched by replacement with approximately 0.1% (w/v) NaBH~4~ (Sigma‐Aldrich) in PBS for 7 min. Subsequently, fixed cells were rinsed three times with 600 μL of PBS and incubated for 10 min in antibody‐diluting buffer (AbDil) consisting of 0.1% (v/v) TX and 2% (w/v) bovine serum albumin (Sigma‐Aldrich) in PBS. Cells were exposed to 600 μL of primary antibody solution containing 1 μg·mL^−1^ monoclonal mouse anti‐β‐tubulin IgG1 (Life Technologies, USA, catalog\# 32‐2600) in AbDil for 30 min. After rinsing four times with 0.1% (v/v) TX in PBS, incubation with donkey anti‐mouse IgG‐Alexa Fluor 647 (1 μg·mL^−1^ in AbDil) (Life Technologies, USA) was performed for 30 min. Then, cells were rinsed four times with PBS containing 0.1% TX and a further four times with pure PBS. A postfixation step was performed by adding 600 μL of 4% (v/v) formaldehyde for 10 min. Finally, cells were rinsed four times with pure PBS. If not imaged immediately, cells were stored in PBS containing 0.05% (w/v) NaN~3~ at 4 °C.

### Staining with fluorescently labeled cholera toxin B {#feb412285-sec-0025}

For staining of cholesterol‐rich regions, living cells were incubated with the respective cytotoxins together with 2 μg·mL^−1^ cholera toxin subunit B‐Alexa Fluor 647 (Life Technologies, USA) in GM for 15 min at 37 °C. Cholera toxin subunit B is known to bind to ganglioside monosialotetrahexosylganglioside (GM1) which is localized in cholesterol‐rich nanodomains [37](#feb412285-bib-0037){ref-type="ref"}. After rinsing with 600 μL of GM, cells were incubated for 15 min at 23 °C. Samples were fixed by the addition of 600 μL of 4% (v/v) formaldehyde in PBS and incubation for 10 min. Once rinsed three times with PBS, cells were imaged or stored in PBS containing 0.05% (w/v) NaN~3~ at 4 °C.

### Setup and data acquisition {#feb412285-sec-0026}

Confocal laser scanning microscopy images were recorded with a LSM 710 (Carl Zeiss AG, Oberkochen, Germany) using a 633 nm laser and an oil immersion objective with 63 × magnification and NA = 1.4. Measurements were taken with the ZEN software (Carl Zeiss AG) using the following settings: an image size of 512 × 512 pixels, a scanning speed of 1 (pixel dwell time = 1.58 μs, scan time = 968.14 ms), no averaging, a bit depth of 16 bit, and a master gain of 800. The pinhole was adjusted to 1 Airy unit. A laser power of 15% was chosen. 10--20 cells were imaged for each condition.

For analysis, images were processed with [imagej]{.smallcaps}. Brightness and contrast were adjusted homogeneously for images showing the same cellular structures in order to compare cytotoxin‐treated cells to the respective control samples.

Results and Discussion {#feb412285-sec-0027}
======================

Resting receptors exhibit higher diffusion coefficients than activated MET {#feb412285-sec-0028}
--------------------------------------------------------------------------

We probed the diffusion dynamics of MET in living HeLa cells using uPAINT by applying two different ligands for MET, each carrying the fluorophore ATTO 647N. First, a monoclonal Fab fragment, which binds but does not activate MET, was deployed. Second, the bacterial protein fragment InlB~321~ was used (Fig. [1](#feb412285-fig-0001){ref-type="fig"}A). Cells were either investigated untreated or exposed to a cytotoxin affecting cell morphology and endocytosis pathways prior to analysis.

![Diffusion dynamics of MET studied by uPAINT. (A) A monoclonal Fab fragment was used that binds but does not activate MET. InlB~321~ binds and activates the receptor. Both ligands were fluorescently labeled with ATTO 647N. (B) Distribution of diffusion coefficients (*N* = 60 cells) from uPAINT experiments for resting and InlB~~‐~~bound MET in living HeLa cells at 23 °C (SEMs are depicted as error bars). (C) Relative occurrences of immobile, confined, and freely diffusing particles of resting and InlB‐bound receptors.](FEB4-7-1422-g001){#feb412285-fig-0001}

First, we studied MET in untreated cells incubated with 0.25 n[m]{.smallcaps} Fab or InlB~321~ at 23 °C and extracted the diffusion coefficients of the receptors. The distribution of diffusion coefficients showed that diffusion of InlB~321~/MET complexes is slower than that of resting MET (Fig. [1](#feb412285-fig-0001){ref-type="fig"}B). Analysis of diffusion types indicated a large immobile fraction for InlB‐bound receptors (Fig. [1](#feb412285-fig-0001){ref-type="fig"}C). While InlB~321~/MET had a mean diffusion coefficient of 0.085 ± 0.003 μm^2^·s^−1^, Fab/MET yielded an average coefficient of 0.126 ± 0.005 μm^2^·s^−1^ (Fig. [2](#feb412285-fig-0002){ref-type="fig"}, Table [1](#feb412285-tbl-0001){ref-type="table-wrap"}). Regardless of whether cells were cytotoxin‐treated or not, MET bound by Fab exhibited approximately 40% higher diffusion coefficients than receptors bound by InlB~321~ with a high significance (Fig. [2](#feb412285-fig-0002){ref-type="fig"}, Table [1](#feb412285-tbl-0001){ref-type="table-wrap"}, two‐sample *t*‐tests in Table [2](#feb412285-tbl-0002){ref-type="table-wrap"}).

![uPAINT mean diffusion coefficients of resting and InlB‐bound MET. Mean diffusion coefficients were determined for both ligand/MET complexes in living HeLa cells in combination with different cytotoxins. The box plot of diffusion coefficients (*N* = 60 cells) displays 5th percentile, 25th percentile, median (line), mean (square), 75th percentile, and 95th percentile. Results of two‐sample t‐tests comparing untreated cells with cells exposed to cytotoxins are depicted (*P* \> 0.05 no significant difference between means (n.s.), *P* \< 0.01 very significant difference (\*\*), *P* \< 0.001 highly significant difference (\*\*\*)).](FEB4-7-1422-g002){#feb412285-fig-0002}

###### 

Diffusion coefficients of resting and InlB‐bound MET. The table lists the mean diffusion coefficients for 60 cells as well as mean values according to diffusion types with their respective SEMs for both ligand/MET complexes in combination with different cytotoxins

                      *D* (μm^2^·s^−1^)                                     
  ------------------- ------------------- ----------------- --------------- ---------------
  Fab                 0.126 ± 0.005       0.0017 ± 0.0002   0.097 ± 0.006   0.162 ± 0.008
  \+ cytochalasin D   0.123 ± 0.005       0.0017 ± 0.0003   0.101 ± 0.006   0.160 ± 0.008
  \+ latrunculin A    0.145 ± 0.006       0.0017 ± 0.0004   0.109 ± 0.009   0.183 ± 0.010
  \+ MCD              0.080 ± 0.003       0.0018 ± 0.0002   0.066 ± 0.004   0.113 ± 0.006
  \+ nystatin         0.116 ± 0.006       0.0016 ± 0.0002   0.082 ± 0.006   0.183 ± 0.013
  \+ colchicine       0.120 ± 0.006       0.0017 ± 0.0003   0.096 ± 0.008   0.157 ± 0.010
  At 32 °C            0.245 ± 0.005       0.0017 ± 0.0004   0.174 ± 0.013   0.306 ± 0.013
  InlB~321~           0.085 ± 0.003       0.0017 ± 0.0001   0.051 ± 0.004   0.125 ± 0.005
  \+ cytochalasin D   0.102 ± 0.002       0.0018 ± 0.0002   0.056 ± 0.004   0.141 ± 0.006
  \+ latrunculin A    0.135 ± 0.008       0.0017 ± 0.0001   0.073 ± 0.005   0.185 ± 0.007
  \+ MCD              0.056 ± 0.002       0.0017 ± 0.0002   0.039 ± 0.004   0.090 ± 0.006
  \+ nystatin         0.089 ± 0.004       0.0016 ± 0.0002   0.058 ± 0.023   0.150 ± 0.013
  \+ colchicine       0.081 ± 0.002       0.0017 ± 0.0002   0.046 ± 0.004   0.116 ± 0.006
  At 32 °C            0.194 ± 0.003       0.0019 ± 0.0002   0.095 ± 0.008   0.244 ± 0.008
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###### 

Two‐sample *t*‐tests comparing mean diffusion coefficients from MSD fits. *t*‐Values, degrees of freedom (df), *P*‐values, and levels of significance (LOS) from two‐sample t‐tests (α = 0.05) are listed. The sample of InlB~321~ + latrunculin A was not normally distributed according to the Kolmogorov--Smirnov test (α = 0.1). LOS are classified as follows: *P* \> 0.05 no significant difference between means (n.s.), *P* \< 0.01 very significant difference (\*\*), and *P* \< 0.001 highly significant difference (\*\*\*)

  Sample 1                    Sample 2                     *t*    df        *P*      LOS
  --------------------------- ---------------------------- ------ --------- -------- --------
  Fab                         Fab + cytochalasin D         0.7    118       0.5      n.s.
  Fab + latrunculin A         3.2                          118    0.002     \*\*     
  Fab + MCD                   10.7                         118    3.4E‐19   \*\*\*   
  Fab + nystatin              1.7                          118    0.09      n.s.     
  Fab + colchicine            1.4                          118    0.2       n.s.     
  Fab at 32 °C                19.0                         118    1E‐37     \*\*\*   
  InlB~321~                   InlB~321~ + cytochalasin D   6.0    118       3E‐08    \*\*\*
  InlB~321~ + latrunculin A   6.4                          118    3E‐09     \*\*\*   
  InlB~321~ + MCD             11.5                         118    5E‐21     \*\*\*   
  InlB~321~ + nystatin        0.9                          118    0.4       n.s.     
  InlB~321~ + colchicine      1.6                          118    0.1       n.s.     
  InlB~321~ at 32 °C          30.1                         118    3E‐57     \*\*\*   
  Fab                         InlB~321~                    10.1   118       1E‐17    \*\*\*
  Fab + cytochalasin D        InlB~321~ + cytochalasin D   5.3    118       6E‐07    \*\*\*
  Fab + latrunculin A         InlB~321~ + latrunculin A    1.1    118       0.3      n.s.
  Fab + MCD                   InlB~321~ + MCD              8.1    118       6E‐13    \*\*\*
  Fab + nystatin              InlB~321~ + nystatin         4.6    118       1E‐05    \*\*\*
  Fab + colchicine            InlB~321~ + colchicine       10.4   118       3E‐18    \*\*\*
  Fab at 32 °C                InlB~321~ at 32 °C           8.5    118       7E‐14    \*\*\*

John Wiley & Sons, Ltd

In order to assess how temperature influences the diffusion coefficient of resting and InlB‐bound MET, we performed uPAINT experiments at 32 °C (c~ligand~ = 0.1 n[m]{.smallcaps}). As expected, the absolute diffusion coefficient increased according to the influence of temperature on membrane fluidity [38](#feb412285-bib-0038){ref-type="ref"}. The ratio between the diffusion coefficients of Fab/MET and InlB/MET remained constant (Table [1](#feb412285-tbl-0001){ref-type="table-wrap"}). All further experiments were performed at 23 °C.

Diffusion coefficients of InlB‐bound and resting MET were also determined by imFCS (Fig. [3](#feb412285-fig-0003){ref-type="fig"}). Resting MET receptors were found to exhibit distinctly higher diffusion coefficients (0.197 ± 0.005 μm^2^·s^−1^) than InlB/MET (0.103 ± 0.003 μm^2^·s^−1^). The deviation from uPAINT is probably due to the fact that immobile particles cannot be detected by imFCS. Consistently, we found that diffusion coefficients of resting receptors are significantly higher than those of InlB~321~/MET complexes.

![Relative occurrence of MET diffusion coefficients obtained by imFCS. A distribution of diffusion coefficients obtained by imFCS of InlB‐bound and resting MET at 23 °C was plotted (*N* = 60 cells). Distributions are shifted to higher diffusion coefficients compared to uPAINT data as imFCS does not recognize immobile particles. SEMs are depicted as error bars.](FEB4-7-1422-g003){#feb412285-fig-0003}

On the one hand, the observed ratio of diffusion coefficients between resting and InlB‐bound receptors supports the hypothesis that receptors are slowed by InlB binding possibly due to immobilization. On the other hand, this ratio might also be influenced by the increased occurrence of dimers in InlB‐activated cells [11](#feb412285-bib-0011){ref-type="ref"}. A study on epidermal growth factor receptor (EGFR) observed a factor of 2 between monomeric and dimeric diffusion coefficients by analyzing individual trajectories [39](#feb412285-bib-0039){ref-type="ref"}. Diffusion of the neurotrophin receptor tropomyosin‐related kinase A was also found to decelerate and to be more confined upon ligand binding due to receptor oligomerization [40](#feb412285-bib-0040){ref-type="ref"}.

In comparison with other RTKs, ligand/MET complexes exhibit high diffusion coefficients {#feb412285-sec-0029}
---------------------------------------------------------------------------------------

Diffusion coefficients of various RTKs span about three orders of magnitude (0.001--0.47 μm^2^·s^−1^) [39](#feb412285-bib-0039){ref-type="ref"}, [40](#feb412285-bib-0040){ref-type="ref"}, [41](#feb412285-bib-0041){ref-type="ref"}, [42](#feb412285-bib-0042){ref-type="ref"}, with MET belonging to the RTKs with high diffusion coefficients. For example, diffusion coefficients of 0.04 μm^2^·s^−1^ at 23 °C and of 0.001--0.01 μm^2^·s^−1^ at 37 °C were found for the insulin receptor using fluorescence photobleaching recovery. In the same study, diffusion coefficients of EGFR were found to be similar to those of the insulin receptor. The decrease in mobility with increasing temperature was explained by the more rapid aggregation and subsequent endocytosis of activated receptors at 37 °C [42](#feb412285-bib-0042){ref-type="ref"}. MET displayed a contrary behavior, with diffusion coefficients increasing with rising temperature for both resting and InlB‐bound receptors (Table [1](#feb412285-tbl-0001){ref-type="table-wrap"}). This effect could be due to decreasing membrane viscosity. A diffusion coefficient of 0.2 μm^2^·s^−1^ was observed for resting EGFR using imFCS [41](#feb412285-bib-0041){ref-type="ref"}. Examination of EGFR by single‐particle tracking yielded diffusion coefficients of 0.17 μm^2^·s^−1^ for monomers and 0.08 μm^2^·s^−1^ for preformed dimers. Upon binding of a ligand, diffusion coefficients were diminished to about 0.017 μm^2^·s^−1^ [39](#feb412285-bib-0039){ref-type="ref"}. Chung *et al*. discussed that this reduction in mobility is due to interaction with signaling proteins and preceding endocytosis. A similar mechanism can probably be assumed for MET which also exhibited decreased diffusion coefficients in the InlB‐bound state.

Diffusion‐type analysis reveals a distinct immobile fraction for InlB~321~/MET complexes {#feb412285-sec-0030}
----------------------------------------------------------------------------------------

We determined the diffusion types for MET from uPAINT data by MSD analysis. The mean diffusion coefficient (Table [1](#feb412285-tbl-0001){ref-type="table-wrap"}) and relative occurrence (Table [3](#feb412285-tbl-0003){ref-type="table-wrap"}) of each diffusion type were calculated. In the case of MET bound to Fab, the immobile population was smaller than the confined population (paired *t*‐test immobile vs. confined: *P* = 3E‐7). The population of freely diffusing complexes was dominant (paired *t*‐test free vs. confined: *P* = 3E‐5). InlB~321~‐bound MET displayed a small confined fraction, while the immobile population was significantly larger (paired t‐test immobile vs. confined: *P* = 0.005). The freely diffusing population was biggest (paired *t*‐test free vs. immobile: *P* = 5E‐26). Comparing InlB~321~ and Fab, the latter exhibited a distinctly smaller immobile population, while the confined population was significantly larger. The relative occurrences of free MET receptors showed no significant difference between the two ligands. However, the diffusion coefficients of freely and confined diffusing Fab/MET complexes were significantly higher than those of the corresponding populations of InlB~321~/MET. Observations of the same ligands at 32 °C revealed even higher diffusion coefficients for both mobile fractions. In both cases, temperature increase resulted in a decrease in the immobile fraction and a simultaneous increase in the mobile population (two‐sample *t*‐tests in Tables [4](#feb412285-tbl-0004){ref-type="table-wrap"}, [5](#feb412285-tbl-0005){ref-type="table-wrap"}, [6](#feb412285-tbl-0006){ref-type="table-wrap"}, [7](#feb412285-tbl-0007){ref-type="table-wrap"}, [8](#feb412285-tbl-0008){ref-type="table-wrap"}, [9](#feb412285-tbl-0009){ref-type="table-wrap"}).

###### 

Relative occurrences of diffusion types of resting and InlB‐bound MET. The table lists the mean relative occurrences of diffusion types (*N* = 60 cells) with respective SEMs for both ligand/MET complexes in combination with different cytotoxins

                      Relative occurrence (%)            
  ------------------- ------------------------- -------- --------
  Fab                 12 ± 1                    31 ± 3   57 ± 3
  \+ cytochalasin D   12 ± 1                    38 ± 3   50 ± 3
  \+ latrunculin A    10 ± 1                    31 ± 3   59 ± 3
  \+ MCD              16 ± 1                    38 ± 3   47 ± 2
  \+ nystatin         24 ± 3                    28 ± 3   48 ± 3
  \+ colchicine       13 ± 1                    36 ± 3   52 ± 3
  At 32 °C            7.2 ± 0.4                 33 ± 2   60 ± 2
  InlB~321~           23 ± 1                    17 ± 2   60 ± 1
  \+ cytochalasin D   17 ± 1                    19 ± 2   64 ± 2
  \+ latrunculin A    18 ± 1                    18 ± 2   64 ± 2
  \+ MCD              26 ± 1                    22 ± 2   51 ± 2
  \+ nystatin         25 ± 1                    23 ± 3   52 ± 3
  \+ colchicine       23 ± 1                    18 ± 2   59 ± 2
  At 32 °C            10 ± 1                    19 ± 2   70 ± 2
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###### 

Two‐sample *t*‐tests for diffusion coefficients from immobile subpopulations. *t*‐Values, degrees of freedom (df), p‐values, and levels of significance (LOS) from two‐sample *t*‐tests (α = 0.05) are listed. The sample of InlB~321~ at 32 °C was not normally distributed according to the Kolmogorov--Smirnov test (α = 0.1). LOS are classified as follows: *P* \> 0.05 no significant difference between means (n.s.), *P* \< 0.05 significant difference (\*), and *P* \< 0.01 very significant difference (\*\*)

  Sample 1                    Sample 2                     *t*   df      *P*    LOS
  --------------------------- ---------------------------- ----- ------- ------ ------
  Fab                         Fab + cytochalasin D         0.3   118     0.8    n.s.
  Fab + latrunculin A         0.9                          118   0.4     n.s.   
  Fab + MCD                   0.9                          118   0.4     n.s.   
  Fab + nystatin              1.9                          118   0.06    n.s.   
  Fab + colchicine            0.1                          118   0.9     n.s.   
  Fab at 32 °C                0.4                          117   0.7     n.s.   
  InlB~321~                   InlB~321~ + cytochalasin D   2.3   115     0.02   \*
  InlB~321~ + latrunculin A   1.2                          115   0.2     n.s.   
  InlB~321~ + MCD             1.7                          115   0.1     n.s.   
  InlB~321~ + nystatin        0.5                          115   0.6     n.s.   
  InlB~321~ + colchicine      0.7                          115   0.5     n.s.   
  InlB~321~ at 32 °C          2.9                          114   0.004   \*\*   
  Fab                         InlB~321~                    1.1   115     0.3    n.s.
  Fab + cytochalasin D        InlB~321~ + cytochalasin D   0.8   118     0.4    n.s.
  Fab + latrunculin A         InlB~321~ + latrunculin A    0.9   118     0.4    n.s.
  Fab + MCD                   InlB~321~ + MCD              0.4   118     0.7    n.s.
  Fab + nystatin              InlB~321~ + nystatin         0.5   118     0.6    n.s.
  Fab + colchicine            InlB~321~ + colchicine       0.3   118     0.8    n.s.
  Fab at 32 °C                InlB~321~ at 32 °C           1.6   116     0.1    n.s.
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###### 

Two‐sample *t*‐tests for diffusion coefficients from confined subpopulations. *T*‐Values, degrees of freedom (df), *P*‐values, and levels of significance (LOS) from two‐sample *t*‐tests (α = 0.05) are listed. All samples were normally distributed according to the Kolmogorov--Smirnov test (α = 0.1). LOS are classified as follows: *P* \> 0.05 no significant difference between means (n.s.), *P* \< 0.01 very significant difference (\*\*), and *P* \< 0.001 highly significant difference (\*\*\*)

  Sample 1                    Sample 2                     *t*   df      *P*      LOS
  --------------------------- ---------------------------- ----- ------- -------- --------
  Fab                         Fab + cytochalasin D         0.6   112     0.5      n.s.
  Fab + latrunculin A         1.6                          110   0.1     n.s.     
  Fab + MCD                   5.0                          113   2E‐06   \*\*\*   
  Fab + nystatin              1.9                          111   0.06    n.s.     
  Fab + colchicine            0.2                          112   0.9     n.s.     
  Fab at 32 °C                7.9                          112   2E‐12   \*\*\*   
  InlB~321~                   InlB~321~ + cytochalasin D   1.3   111     0.2      n.s.
  InlB~321~ + latrunculin A   3.2                          109   0.002   \*\*     
  InlB~321~ + MCD             3.0                          114   0.003   \*\*     
  InlB~321~ + nystatin        1.6                          107   0.1     n.s.     
  InlB~321~ + colchicine      1.1                          113   0.3     n.s.     
  InlB~321~ at 32 °C          5.5                          109   2E‐07   \*\*\*   
  Fab                         InlB~321~                    7.4   109     3E‐11    \*\*\*
  Fab + cytochalasin D        InlB~321~ + cytochalasin D   7.5   114     1E‐11    \*\*\*
  Fab + latrunculin A         InlB~321~ + latrunculin A    4.3   110     3E‐05    \*\*\*
  Fab + MCD                   InlB~321~ + MCD              7.4   118     2E‐11    \*\*\*
  Fab + nystatin              InlB~321~ + nystatin         3.4   109     9E‐04    \*\*\*
  Fab + colchicine            InlB~321~ + colchicine       8.5   116     7E‐14    \*\*\*
  Fab at 32 °C                InlB~321~ at 32 °C           7.2   112     8E‐11    \*\*\*

John Wiley & Sons, Ltd

###### 

Two‐sample *t*‐tests for diffusion coefficients from free subpopulations. *t*‐Values, degrees of freedom (df), *P*‐values, and levels of significance (LOS) from two‐sample *t*‐tests (α = 0.05) are listed. The samples of InlB~321~ + nystatin, InlB~321~ + Latrunculin A, and Fab + cytochalasin D were not normally distributed according to the Kolmogorov--Smirnov test (α = 0.1). LOS are classified as follows: *P* \> 0.05 no significant difference between means (n.s.), *P* \< 0.01 very significant difference (\*\*), and *P* \< 0.001 highly significant difference (\*\*\*)

  Sample 1                    Sample 2                     *t*   df      *P*      LOS
  --------------------------- ---------------------------- ----- ------- -------- --------
  Fab                         Fab + cytochalasin D         0.3   118     0.7      n.s.
  Fab + latrunculin A         2.7                          118   0.007   \*\*     
  Fab + MCD                   8.8                          118   1E‐14   \*\*\*   
  Fab + nystatin              2.8                          118   0.006   \*\*     
  Fab + colchicine            0.9                          118   0.4     n.s.     
  Fab at 32 °C                18.7                         118   5E‐37   \*\*\*   
  InlB~321~                   InlB~321~ + cytochalasin D   4.4   115     3E‐05    \*\*\*
  InlB~321~ + latrunculin A   5.7                          115   1E‐07   \*\*\*   
  InlB~321~ + MCD             9.7                          115   1E‐16   \*\*\*   
  InlB~321~ + nystatin        2.9                          115   0.004   \*\*     
  InlB~321~ + colchicine      2.7                          115   0.009   \*\*     
  InlB~321~ at 32 °C          23.3                         115   2E‐45   \*\*\*   
  Fab                         InlB~321~                    7.1   115     9E‐11    \*\*\*
  Fab + cytochalasin D        InlB~321~ + cytochalasin D   3.7   118     3E‐04    \*\*\*
  Fab + latrunculin A         InlB~321~ + latrunculin A    0.2   118     0.9      n.s.
  Fab + MCD                   InlB~321~ + MCD              5.6   118     2E‐07    \*\*\*
  Fab + nystatin              InlB~321~ + nystatin         3.2   118     0.002    \*\*
  Fab + colchicine            InlB~321~ + colchicine       9.6   118     2E‐16    \*\*\*
  Fab at 32 °C                InlB~321~ at 32 °C           8.2   118     4E‐13    \*\*\*
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###### 

Two‐sample *t*‐tests for relative occurrences from immobile subpopulations. *t*‐Values, degrees of freedom (df), *P*‐values, and levels of significance (LOS) from two‐sample *t*‐tests (α = 0.05) are listed. The samples of Fab, Fab + nystatin, and Fab + cytochalasin D were not normally distributed according to the Kolmogorov--Smirnov test (α = 0.1). LOS are classified as follows: *P* \> 0.05 no significant difference between means (n.s.), *P* \< 0.01 very significant difference (\*\*), and *P* \< 0.001 highly significant difference (\*\*\*)

  Sample 1                    Sample 2                     *t*   df      *P*      LOS
  --------------------------- ---------------------------- ----- ------- -------- --------
  Fab                         Fab + cytochalasin D         0.5   118     0.6      n.s.
  Fab + latrunculin A         2.7                          118   0.008   \*\*     
  Fab + MCD                   3.4                          118   0.001   \*\*     
  Fab + nystatin              4.3                          118   4E‐05   \*\*\*   
  Fab + colchicine            0.4                          118   0.7     n.s.     
  Fab at 32 °C                5.9                          118   4E‐08   \*\*\*   
  InlB~321~                   InlB~321~ + cytochalasin D   4.7   115     9E‐06    \*\*\*
  InlB~321~ + latrunculin A   3.7                          115   3E‐04   \*\*\*   
  InlB~321~ + MCD             1.9                          115   0.06    n.s.     
  InlB~321~ + nystatin        0.8                          115   0.4     n.s.     
  InlB~321~ + colchicine      0.5                          115   0.6     n.s.     
  InlB~321~ at 32 °C          11.0                         115   1E‐19   \*\*\*   
  Fab                         InlB~321~                    8.3   115     2E‐13    \*\*\*
  Fab + cytochalasin D        InlB~321~ + cytochalasin D   6.2   118     8E‐09    \*\*\*
  Fab + latrunculin A         InlB~321~ + latrunculin A    6.5   118     2E‐09    \*\*\*
  Fab + MCD                   InlB~321~ + MCD              7.7   118     4E‐12    \*\*\*
  Fab + nystatin              InlB~321~ + nystatin         0.3   118     0.7      n.s.
  Fab + colchicine            InlB~321~ + colchicine       9.5   118     3E‐16    \*\*\*
  Fab at 32 °C                InlB~321~ at 32 °C           4.8   118     5E‐06    \*\*\*
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###### 

Two‐sample *t*‐tests for relative occurrences from confined subpopulations. *t*‐Values, degrees of freedom (df), *P*‐values, and levels of significance (LOS) from two‐sample *t*‐tests (α = 0.05) are listed. The samples of InlB~321~ + nystatin and Fab + cytochalasin D were not normally distributed according to the Kolmogorov--Smirnov test (α = 0.1). LOS are classified as follows: *P* \> 0.05 no significant difference between means (n.s.), *P* \< 0.05 significant difference (\*), and *P* \< 0.001 highly significant difference (\*\*\*)

  Sample 1                    Sample 2                     *t*   df     *P*     LOS
  --------------------------- ---------------------------- ----- ------ ------- --------
  Fab                         Fab + cytochalasin D         1.7   118    0.1     n.s.
  Fab + latrunculin A         0.1                          118   0.9    n.s.    
  Fab + MCD                   1.7                          118   0.09   n.s.    
  Fab + nystatin              0.8                          118   0.4    n.s.    
  Fab + colchicine            1.1                          118   0.3    n.s.    
  Fab at 32 °C                0.4                          118   0.7    n.s.    
  InlB~321~                   InlB~321~ + cytochalasin D   0.8   115    0.4     n.s.
  InlB~321~ + latrunculin A   0.6                          115   0.6    n.s.    
  InlB~321~ + MCD             1.9                          115   0.06   n.s.    
  InlB~321~ + nystatin        2.0                          115   0.05   \*      
  InlB~321~ + colchicine      0.4                          115   0.7    n.s.    
  InlB~321~ at 32 °C          0.9                          115   0.4    n.s.    
  Fab                         InlB~321~                    4.3   115    4E‐05   \*\*\*
  Fab + cytochalasin D        InlB~321~ + cytochalasin D   5.5   118    2E‐07   \*\*\*
  Fab + latrunculin A         InlB~321~ + latrunculin A    4.0   118    1E‐04   \*\*\*
  Fab + MCD                   InlB~321~ + MCD              4.3   118    3E‐05   \*\*\*
  Fab + nystatin              InlB~321~ + nystatin         1.1   118    0.3     n.s.
  Fab + colchicine            InlB~321~ + colchicine       5.1   118    1E‐06   \*\*\*
  Fab at 32 °C                InlB~321~ at 32 °C           4.0   118    1E‐04   \*\*\*
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###### 

Two‐sample *t*‐tests for relative occurrences from free subpopulations. T‐values, degrees of freedom (df), *P*‐values, and levels of significance (LOS) from two‐sample *t*‐tests (α = 0.05) are listed. The sample of Fab was not normally distributed according to the Kolmogorov--Smirnov test (α = 0.1). LOS are classified as follows: *P* \> 0.05 no significant difference between means (n.s.), *P* \< 0.05 significant difference (\*), *P* \< 0.01 very significant difference (\*\*), and *P* \< 0.001 highly significant difference (\*\*\*)

  Sample 1                    Sample 2                     *t*   df      *P*      LOS
  --------------------------- ---------------------------- ----- ------- -------- --------
  Fab                         Fab + cytochalasin D         1.6   118     0.1      n.s.
  Fab + latrunculin A         0.6                          118   0.5     n.s.     
  Fab + MCD                   2.7                          118   0.009   \*\*     
  Fab + nystatin              2.1                          118   0.03    \*       
  Fab + colchicine            1.2                          118   0.2     n.s.     
  Fab at 32 °C                1.0                          118   0.3     n.s.     
  InlB~321~                   InlB~321~ + cytochalasin D   1.5   115     0.1      n.s.
  InlB~321~ + latrunculin A   1.8                          115   0.07    n.s.     
  InlB~321~ + MCD             3.3                          115   0.001   \*\*     
  InlB~321~ + nystatin        2.5                          115   0.01    \*       
  InlB~321~ + colchicine      0.2                          115   0.9     n.s.     
  InlB~321~ at 32 °C          3.8                          115   2E‐04   \*\*\*   
  Fab                         InlB~321~                    1.1   115     0.3      n.s.
  Fab + cytochalasin D        InlB~321~ + cytochalasin D   4.0   118     1E‐04    \*\*\*
  Fab + latrunculin A         InlB~321~ + latrunculin A    1.6   118     0.1      n.s.
  Fab + MCD                   InlB~321~ + MCD              1.4   118     0.2      n.s.
  Fab + nystatin              InlB~321~ + nystatin         0.9   118     0.4      n.s.
  Fab + colchicine            InlB~321~ + colchicine       2.3   118     0.02     \*
  Fab at 32 °C                InlB~321~ at 32 °C           3.0   118     0.003    \*\*
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As a second approach, we used cumulative analysis [33](#feb412285-bib-0033){ref-type="ref"} to determine populations of different diffusion coefficients. Cumulative occurrences were fitted with a one‐ and a two‐population function (Fig. [4](#feb412285-fig-0004){ref-type="fig"}, Table [10](#feb412285-tbl-0010){ref-type="table-wrap"}). An attempt to fit the plots with a three population function failed. Most likely, diffusion coefficients of the confined and free subpopulation are too similar and cannot be differentiated by cumulative analysis. In general, the two‐population fit converged better than the one‐population fit, indicating a mobile and an immobile fraction. However, the mobile fraction of InlB/MET decreases compared to resting receptors as indicated by the lower amplitude in the two‐population fit. This suggests that InlB~321~/MET is immobilized to a higher extent than MET bound by Fab.

![Cumulative occurrences of diffusion coefficients of resting and InlB‐bound MET. Diffusion coefficients and their respective SEMs in living HeLa cells (*N* = 60) at 23 °C are depicted. Plots were fitted with a one‐ and a two‐population function using Eqns [(4)](#feb412285-disp-0004){ref-type="disp-formula"} and [(5)](#feb412285-disp-0005){ref-type="disp-formula"}. Residuals are shown below.](FEB4-7-1422-g004){#feb412285-fig-0004}

###### 

Diffusion coefficients and amplitudes from the fits of cumulative occurrences. Results with respective SEMs are shown for one‐ and two‐population fits (Eqns [(4)](#feb412285-disp-0004){ref-type="disp-formula"} and [(5)](#feb412285-disp-0005){ref-type="disp-formula"}) of the mean cumulative occurrences of diffusion coefficients obtained by uPAINT at 23 and 32 °C (*N* = 60 cells). Amplitudes signify the relative proportion of particles whose motion can be described accurately by the respective diffusion coefficient

                      One population   Two populations                                 
  ------------------- ---------------- ----------------- ------------- --------------- ---------------
  Fab                 1.00 ± 0.01      0.119 ± 0.005     0.94 ± 0.01   0.134 ± 0.004   4E‐4 ± 9E‐4
  \+ cytochalasin D   1.00 ± 0.01      0.119 ± 0.005     0.95 ± 0.01   0.131 ± 0.004   2E‐4 ± 1E‐3
  \+ latrunculin A    1.00 ± 0.01      0.143 ± 0.005     0.96 ± 0.01   0.153 ± 0.005   3E‐6 ± 0
  \+ MCD              1.00 ± 0.01      0.067 ± 0.003     0.92 ± 0.01   0.080 ± 0.001   5E‐4 ± 2E‐4
  \+ nystatin         0.98 ± 0.02      0.077 ± 0.008     0.79 ± 0.01   0.135 ± 0.002   0.001 ± 9E‐5
  \+ colchicine       1.00 ± 0.01      0.116 ± 0.005     0.94 ± 0.01   0.130 ± 0.004   2E‐4 ± 2E‐3
  At 32 °C            1.01 ± 0.01      0.259 ± 0.011     0.97 ± 0.01   0.269 ± 0.011   1E‐5 ± 0
  InlB~321~           0.98 ± 0.02      0.054 ± 0.004     0.81 ± 0.01   0.089 ± 0.001   0.0014 ± 8E‐5
  \+ cytochalasin D   0.99 ± 0.01      0.076 ± 0.004     0.87 ± 0.01   0.103 ± 0.001   0.0013 ± 7E‐5
  \+ latrunculin A    0.98 ± 0.01      0.091 ± 0.006     0.86 ± 0.01   0.130 ± 0.001   0.0016 ± 1E‐4
  \+ MCD              0.98 ± 0.01      0.036 ± 0.003     0.81 ± 0.01   0.058 ± 0.001   0.0013 ± 8E‐5
  \+ nystatin         0.97 ± 0.02      0.049 ± 0.005     0.76 ± 0.01   0.100 ± 0.001   0.0014 ± 8E‐5
  \+ colchicine       0.98 ± 0.02      0.053 ± 0.004     0.82 ± 0.01   0.084 ± 0.001   0.0014 ± 7E‐5
  At 32 °C            1.00 ± 0.01      0.176 ± 0.008     0.92 ± 0.01   0.205 ± 0.004   0.0013 ± 4E‐4
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Confinement radii were determined for both ligand/MET complexes (Fig. [5](#feb412285-fig-0005){ref-type="fig"}). Particles can either be confined by actin or by nanodomains, for example, sterol‐rich regions [20](#feb412285-bib-0020){ref-type="ref"}. Domains confined by actin are thought to have a confinement radius of 0.2--0.6 μm [20](#feb412285-bib-0020){ref-type="ref"}. Diffusion hampered by nanodomains exhibits even smaller radii, ranging from 10 nm up to 200 nm [14](#feb412285-bib-0014){ref-type="ref"}. Confinement radii of untreated cells amounted to 0.276 ± 0.021 μm for Fab/MET and 0.188 ± 0.022 μm for InlB~321~/MET. At 32 °C, confinement radii increased for both ligands (0.376 ± 0.027 μm for Fab/MET, 0.249 ± 0.022 μm for InlB~321~/MET). These values are in the range of both the domain size of confinement by actin and of nanodomains.

![Cumulative occurrences of confinement radii for resting and InlB‐bound MET. Cumulative occurrences of confinement radii for InlB~321~/MET and Fab/MET obtained from the uPAINT data are shown (*N* = 60 cells). Error bars represent the SEMs of individual data points.](FEB4-7-1422-g005){#feb412285-fig-0005}

Diffusion coefficients, diffusion types, and confinement radii suggest that resting MET diffuses more freely than MET bound by InlB~321~. This may support the hypothesis of immobilization prior to endocytosis as also discussed by Chung *et al*. for EGFR [39](#feb412285-bib-0039){ref-type="ref"}. Lower diffusion coefficients and a higher immobile population of InlB~321~‐bound receptors might be due to the formation of a signaling complex comprising several proteins, such as growth factor receptor‐bound protein 2 (Grb2) or Grb2‐associated binding protein 1 (Gab1) [3](#feb412285-bib-0003){ref-type="ref"}, [43](#feb412285-bib-0043){ref-type="ref"}, [44](#feb412285-bib-0044){ref-type="ref"}, [45](#feb412285-bib-0045){ref-type="ref"} and coreceptors such as CD44v6 [46](#feb412285-bib-0046){ref-type="ref"}.

Perturbing actin polymerization and depletion of cholesterol influence MET diffusion {#feb412285-sec-0031}
------------------------------------------------------------------------------------

The effects of actin, cholesterol, and microtubules on plasma membrane mobility of MET were studied by uPAINT in living cells after exposure to selected cytotoxins. In cells treated with cytochalasin D and latrunculin A, which affect actin polymerization, increased diffusion coefficients were found for InlB~321~/MET. While cytochalasin D caused an increase in the diffusion coefficient by approximately 20%, latrunculin A led to an increase of about 60%. In the case of resting MET bound by Fab, treatment with cytochalasin D did not result in a significant change in the diffusion coefficient, and latrunculin A induced only a slight increase in the diffusion coefficient (Table [1](#feb412285-tbl-0001){ref-type="table-wrap"}, Fig. [2](#feb412285-fig-0002){ref-type="fig"}) resulting in an insignificant difference between diffusion in resting and InlB‐treated cells (two‐sample *t*‐tests in Table [2](#feb412285-tbl-0002){ref-type="table-wrap"}). Latrunculin A disrupts the actin cytoskeleton very effectively (Fig. [6](#feb412285-fig-0006){ref-type="fig"}). Actin is suspected to play an essential role in the immobilization of activated MET [46](#feb412285-bib-0046){ref-type="ref"}. If the actin cytoskeleton is destroyed so that immobilization and confinement of proteins is significantly decreased, the difference in diffusion between resting and InlB‐bound receptors is diminished. This hypothesis is in accordance with Chung *et al*. who suggest that latrunculin treatment lowers the dimerization frequency by increasing the diffusible area, effectively reducing receptor density [39](#feb412285-bib-0039){ref-type="ref"}.

![Effects of cytotoxins on different cellular structures visualized by confocal microscopy. CLSM images of effector‐treated HeLa cells as well as of untreated control samples are represented. After fixation, (A + B) actin was stained with phalloidin‐Alexa Fluor 647, (B) cholesterol‐rich regions were stained with cholera toxin subunit B‐Alexa Fluor 647, and (C) microtubules were immunostained with Alexa Fluor 647. All images were adjusted to the same intensity and contrast as their respective controls in ImageJ (scale bars 10 μm).](FEB4-7-1422-g006){#feb412285-fig-0006}

In order to investigate the influence of cholesterol, cells were exposed to the cholesterol‐depleting cytotoxins MCD and nystatin. While MCD among other effects mainly prevents clathrin‐dependent endocytosis, nystatin inhibits caveolae‐dependent internalization [16](#feb412285-bib-0016){ref-type="ref"}, [18](#feb412285-bib-0018){ref-type="ref"}. Addition of MCD decreased the diffusion coefficients of resting as well as of InlB~321~‐bound receptors with a high significance. Mean diffusion coefficients suggest that treatment with nystatin had no obvious effect on the diffusion of InlB~321~/MET complexes (Table [1](#feb412285-tbl-0001){ref-type="table-wrap"}, Fig. [2](#feb412285-fig-0002){ref-type="fig"}, two‐sample *t*‐tests in Table [2](#feb412285-tbl-0002){ref-type="table-wrap"}).

Cells were exposed to colchicine to study the influence of microtubules on MET diffusion. Neither the diffusion coefficients of Fab/MET nor of InlB~321~/MET were influenced by colchicine treatment ruling out a major role of microtubules in MET diffusion (Table[1](#feb412285-tbl-0001){ref-type="table-wrap"}, Fig. [2](#feb412285-fig-0002){ref-type="fig"}, two‐sample *t*‐tests in Table [2](#feb412285-tbl-0002){ref-type="table-wrap"}).

In addition to calculating overall averaged diffusion coefficients, we also determined the diffusion coefficients of immobile, confined, and freely moving MET populations and their share of all detected particles by MSD analysis for cytotoxin‐treated cells (Tables [1](#feb412285-tbl-0001){ref-type="table-wrap"} and [3](#feb412285-tbl-0003){ref-type="table-wrap"}, two‐sample *t*‐tests in Tables [4](#feb412285-tbl-0004){ref-type="table-wrap"}, [5](#feb412285-tbl-0005){ref-type="table-wrap"}, [6](#feb412285-tbl-0006){ref-type="table-wrap"}, [7](#feb412285-tbl-0007){ref-type="table-wrap"}, [8](#feb412285-tbl-0008){ref-type="table-wrap"}, [9](#feb412285-tbl-0009){ref-type="table-wrap"}). Both actin‐targeting cytotoxins significantly decreased the immobile population of InlB~321~/MET. Additionally, latrunculin A treatment increased the diffusion coefficients of both mobile fractions, while exposure to cytochalasin D only caused a rise in the diffusion coefficient of free receptor. For Fab, there was no significant change in relative occurrences of the populations and their diffusion coefficients after exposure to cytochalasin D. Latrunculin A addition resulted in a slight decrease in the immobile population and a faintly higher diffusion coefficient of freely diffusing particles. Next, cholesterol‐depleting and endocytosis‐inhibiting drugs were tested. Treatment with MCD caused a decrease in the free fraction for both ligands, while the diffusion coefficients of both mobile populations declined sharply. Nystatin exposure resulted in an increase in the diffusion coefficients of the free populations, which could be a result of nystatin rupturing the actin cytoskeleton (Fig. [6](#feb412285-fig-0006){ref-type="fig"}). While effects on the fractions of subpopulations of InlB‐bound receptors were negligible, a highly significant increase in the immobile fraction of resting MET was observed. Exposure to the microtubule‐targeting cytotoxin colchicine did not result in altered diffusion coefficients of subpopulations compared to untreated cells.

Cumulative analysis of diffusion coefficients in cytotoxin‐treated cells (Table [10](#feb412285-tbl-0010){ref-type="table-wrap"}) showed an increased accuracy of the one‐population fit for treatment groups exhibiting small immobile populations and high mean diffusion coefficients (cytochalasin D, latrunculin A) in the MSD analysis (Tables [1](#feb412285-tbl-0001){ref-type="table-wrap"} and [3](#feb412285-tbl-0003){ref-type="table-wrap"}). For groups displaying a distinct immobile population and low mean diffusion coefficients (MCD), the two‐population fit converged much better. Thus, cumulative analysis of subpopulations support the result obtained by MSD analysis.

The effects of the applied cytotoxins on cell integrity were also examined by confocal microscopy (Table [11](#feb412285-tbl-0011){ref-type="table-wrap"}, Fig. [6](#feb412285-fig-0006){ref-type="fig"}). Treatment with cytochalasin D and latrunculin A led to torn and dissolved actin filaments. MCD and nystatin resulted in a decreased staining of cholesterol‐rich domains, and actin filaments became porous and frayed at the cell edges. Colchicine caused the microtubules to loosen and curl.

###### 

Effects of applied cytotoxins. The table lists the effects of the cytotoxins applied to living HeLa cells as well as references where these effects were observed. Impacts on cellular structures marked with (x) were observed in CLSM images (see Fig. [6](#feb412285-fig-0006){ref-type="fig"}) but are not mentioned in the literature

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                   Damage to actin   Damage to microtubules   Cholesterol depletion   Inhibition of clathrin‐mediated endocytosis   Inhibition of caveolae‐dependent endocytosis   References
  ---------------- ----------------- ------------------------ ----------------------- --------------------------------------------- ---------------------------------------------- -------------------------------------------------------------
  Cytochalasin D   x                                                                                                                                                               Cooper [21](#feb412285-bib-0021){ref-type="ref"}

  Latrunculin A    x                                                                                                                                                               Yarmola *et al*. [22](#feb412285-bib-0022){ref-type="ref"}

  MCD              \(x\)                                      x                       x                                             x                                              Yancey *et al*. [15](#feb412285-bib-0015){ref-type="ref"}\
                                                                                                                                                                                   Cubi *et al*. [17](#feb412285-bib-0017){ref-type="ref"}\
                                                                                                                                                                                   Rodal *et al*. [16](#feb412285-bib-0016){ref-type="ref"}

  Nystatin         \(x\)                                      x                                                                     x                                              Ros‐Baro *et al*. [18](#feb412285-bib-0018){ref-type="ref"}

  Colchicine                         x                                                                                                                                             Ravelli *et al*. [24](#feb412285-bib-0024){ref-type="ref"}
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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### Immobilization of InlB~321~‐bound receptors {#feb412285-sec-0032}

The results obtained after treatment with the actin‐targeting drugs cytochalasin D and latrunculin A suggest that immobilization of InlB~321~/MET involves an interaction with the actin cytoskeleton. It was previously supposed that the MET coreceptor CD44v6 interacts with actin via ezrin [46](#feb412285-bib-0046){ref-type="ref"}. At the same time, both drugs had only a small or no effect on resting receptors, supporting the hypothesis that InlB‐bound MET is immobilized preferentially as a first step of endocytosis. Presumably, this difference is due to the fact that InlB‐bound MET receptors are bound to actin by the abovementioned proteins of the signaling cascade [46](#feb412285-bib-0046){ref-type="ref"}, while resting MET seems to be barely affected.

### Treatment with MCD and nystatin influences MET diffusion dynamics {#feb412285-sec-0033}

In cells treated with MCD, we observed lower mean diffusion coefficients for both resting and InlB‐bound MET. Fractions of immobile receptors were increased, diffusion coefficients for the mobile fractions were decreased (Tables [1](#feb412285-tbl-0001){ref-type="table-wrap"} and [3](#feb412285-tbl-0003){ref-type="table-wrap"}), and a better convergence of the two‐population fit in cumulative diffusion coefficient plots was obtained (Table [10](#feb412285-tbl-0010){ref-type="table-wrap"}). These results suggest that clathrin‐dependent endocytosis might play a role in the internalization of active MET, which would be in accordance with the results published by Li *et al*. [8](#feb412285-bib-0008){ref-type="ref"}. As MCD causes clathrin‐coated pits to stay fixed at the cell surface [15](#feb412285-bib-0015){ref-type="ref"}, immobilized receptors would not vanish from the membrane through internalization. However, caveolae‐dependent internalization of MET cannot be ruled out [16](#feb412285-bib-0016){ref-type="ref"}.

An alternative drug that affects cholesterol levels in membranes is nystatin, which has different coeffects including the inhibition of caveolae‐dependent endocytosis [18](#feb412285-bib-0018){ref-type="ref"}. In cells treated with nystatin, we observed only a small effect on the relative occurrence of subpopulations of InlB/MET, while the immobile fraction of Fab/MET significantly increased (Table [3](#feb412285-tbl-0003){ref-type="table-wrap"}). We suspect that resting receptors are immobilized, possibly for subsequent internalization, and that receptor recycling of inactive receptors might be caveolae dependent. For EGFR, it was shown that resting receptors are enriched in caveolae and that EGFR exits from caveolae upon activation and is internalized by clathrin‐coated pits [47](#feb412285-bib-0047){ref-type="ref"}. Future studies have to elucidate whether a similar mechanism holds for MET.

### Microtubules do not influence the diffusion of ligand/MET complexes {#feb412285-sec-0034}

As microtubules play a role in the uptake of *L. monocytogenes* [48](#feb412285-bib-0048){ref-type="ref"}, this cytoskeletal structure was targeted with colchicine. The results of this study showed no effect of colchicine, neither on the diffusion coefficients nor on the proportions of diffusion types. Microtubules did not hinder the diffusion of MET within the cell membrane or harbor binding sites for activated receptors.

Conclusion {#feb412285-sec-0035}
==========

On the basis of this study and by considering previously published data, we come to the following conclusion for the dynamics of resting and InlB‐bound MET receptors. Diffusing receptors can be bound by the bacterial ligand InlB~321~. InlB‐bound receptors exhibit lower diffusion coefficients than resting ones. Previous studies have shown that upon binding by InlB, the dimer population increases [11](#feb412285-bib-0011){ref-type="ref"} and 2 : 2 ligand/MET complexes form [49](#feb412285-bib-0049){ref-type="ref"}. These complexes are bound by proteins and cofactors [46](#feb412285-bib-0046){ref-type="ref"}. Our uPAINT data reveal lower diffusion coefficients and an increased immobile fraction for InlB~321~/MET. Immobilization presumably occurs along the actin cytoskeleton which can be reduced by exposure to actin‐targeting cytotoxins, such as cytochalasin D or latrunculin A. An earlier study reported that InlB‐activated MET receptors are internalized via clathrin‐coated pits [8](#feb412285-bib-0008){ref-type="ref"}. Addition of MCD inhibiting mainly clathrin‐mediated endocytosis but also affecting caveolae‐dependent internalization increased the immobile fraction of InlB~321~/MET complexes in our study.

It remains to be clarified whether differentiation between endocytosis pathways is possibly due to sorting of MET receptors to specific membrane domains, for example, by the actin cytoskeleton. Assays for endocytosis may provide evidence for the proposed endocytosis pathways. The presented results deliver comprehensive details on the diffusion behavior of MET within the cell membrane. Future studies may address how MET receptor complexes initiate intracellular signaling cascades, for example, via Grb2 or Gab1.
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